Human T regulatory cells can use the perforin pathway to cause autologous target cell death

Immunity

Volumn 21, Issue 4, 2004, Pages 589-601

  Grossman, William J ^a   Verbsky, James W ^a   Barchet, Winfried ^b   Colonna, Marco ^b   Atkinson, John P ^b   Ley, Timothy J ^c  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD18 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GRANZYME A; GRANZYME B; INTERLEUKIN 2 RECEPTOR; PERFORIN;

ARTICLE; CELL ADHESION; CELL DEATH; CELL INTERACTION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANTIGENS, CD18; ANTIGENS, CD4; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GRANZYMES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 5644302161     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.09.002     Document Type: Article

References (61)

1. Allen M., De Fusco C., Legrand F., Clementi R., Conter V., Danesino C., Janka G., Arico M. Familial hemophagocytic lymphohistiocytosis. how late can the onset be? Haematologica. 86:2001;499-503
2. Antov A., Yang L., Vig M., Baltimore D., Parijs L.V. Essential role for STAT5 signaling in CD25+4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:2003;3435-3441
3. Arico M., Imashuku S., Clementi R., Hibi S., Teramura T., Danesino C., Haber D.A., Nichols K.E. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood. 97:2001;1131-1133
4. Atkinson J.P., Krych M., Nickells M., Birmingham D., Subramanian V.B., Clemenza L., Alvarez J., Liszewski K. Complement receptors and regulatory proteins. immune adherence revisited and abuse by microorganisms Clin. Exp. Immunol. Suppl. 2:1994;1-3
5. Badovinac V.P., Hamilton S.E., Harty J.T. Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity. 18:2003;463-474
6. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:2001;1245-1253
7. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., Bird P.I. Selective regulation of apoptosis. the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway Mol. Cell. Biol. 18:1998;6387-6398
8. Bird P.I. Serpins and regulation of cell death. Results Probl. Cell Differ. 24:1998;63-89
9. Bladergroen B.A., Strik M.C., Bovenschen N., van Berkum O., Scheffer G.L., Meijer C.J., Hack C.E., Kummer J.A. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J. Immunol. 166:2001;3218-3225
10. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:2003;253-257
11. Bredemeyer A.J., Lewis R.M., Malone J.P., Davis A.E., Gross A.E., Townsend R.R., Ley T.J. A proteomic approach for the discovery of protease substrates. Proc. Natl. Acad. Sci. USA. 101:2004;11785-11790
12. Buzza M.S., Hirst C.E., Bird C.H., Hosking P., McKendrick J., Bird P.I. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell. Immunol. 210:2001;21-29
13. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:2000;R75-R81
14. Clark W.R., Walsh C.M., Glass A.A., Huang M.T., Ahmed R., Matloubian M. Cell-mediated cytotoxicity in perforin-less mice. Int. Rev. Immunol. 13:1995;1-14
15. Day N.E., Ugai H., Yokoyama K.K., Ichiki A.T. K-562 cells lack MHC class II expression due to an alternatively spliced CIITA transcript with a truncated coding region. Leuk. Res. 27:2003;1027-1038
16. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193:2001;1303-1310
17. Dittmer U., He H., Messer R.J., Schmimmer S., Olbrick A.R.M., Ohlen C., Greenberg P.D., Stomnes I.M., Iwashiro M., Sakaguchi S., et al. Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection. Immunity. 20:2004;293-303
18. Dumitriu I.E., Mohr W., Kolowos W., Kern P., Kalden J.R., Herrmann M. 5,6-carboxyfluorescein diacetate succinimidyl ester-labeled apoptotic and necrotic as well as detergent-treated cells can be traced in composite cell samples. Anal. Biochem. 299:2001;247-252
19. Feldman J., Callebaut I., Raposo G., Certain S., Bacq D., Dumont C., Lambert N., Ouachee-Chardin M., Chedeville G., Tamary H., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 115:2003;461-473
20. Gavin M., Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 15:2003;690-696
21. Geppert J.D., Lipsky P.E. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest. 81:1988;1497-1505
22. Grossman W.J., Verbsky J.W., Yang L., Berg L.J., Fields L.E., Chaplin D.D., Ratner L. Dysregulated myelopoiesis in mice lacking Jak3. Blood. 94:1999;932-939
23. Grossman W.J., Revell P.A., Lu Z.H., Johnson H.J., Bredemeyer A.J., Ley T.J. The orphan granzymes of humans and mice. Curr. Opin. Immunol. 15:2003;544-552
24. Grossman, W.J., Verbsky, J.W., Tollefson, B.L., Kemper, C., Atkinson, J.P., and Ley, T.J. (2004). Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood, in press Published online July 6, 2004.
25. Hanson R.D., Sclar G.M., Kanagawa O., Ley T.J. The 5′-flanking region of the human CGL-1/granzyme B gene targets expression of a reporter gene to activated T-lymphocytes in transgenic mice. J. Biol. Chem. 266:1991;24433-24438
26. Hirst C.E., Buzza M.S., Bird C.H., Warren H.S., Cameron P.U., Zhang M., Ashton-Rickardt P.G., Bird P.I. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol. 170:2003;805-815
27. Hirst C.E., Buzza M.S., Sutton V.R., Trapani J.A., Loveland K.L., Bird P.I. Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol. Hum. Reprod. 7:2001;1133-1142
28. Janssens W., Carlier V., Wu B., VanderElst L., Jacquemin M.G., Saint-Remy J.R. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J. Immunol. 171:2003;4604-4612
29. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:2001;1285-1294
30. Jordan M.B., Hildeman D., Kappler J., Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH). CD8+ T cells and interferon gamma are essential for the disorder Blood. 104:2004;735-743
31. Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature. 421:2003;388-392
32. Kingsley C.I., Karim M., Bushell A.R., Wood K.J. CD25+CD4+ regulatory T cells prevent graft rejection. CTLA-4- and IL-10-dependent immunoregulation of alloresponses J. Immunol. 168:2002;1080-1086
33. Lecoeur H., Fevrier M., Garcia S., Riviere Y., Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods. 253:2001;177-187
34. Levings M.K., Sangregorio R., Roncarolo M.G. Human CD25(+)CD4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:2001;1295-1302
35. Levings M.K., Sangregorio R., Sartirana C., Moschin A.L., Battaglia M., Orban P.C., Roncarolo M.G. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:2002;1335-1346
36. Lieberman J. The ABCs of granule-mediated cytotoxicity. new weapons in the arsenal Nat. Rev. Immunol. 3:2003;1-12
37. Lindahl, G., Sjobring, U., and Johnsson, E. (2000). Human complement regulators: a major target for pathogenic microorganisms. 44-51.
38. Malipiero U., Frei K., Spanaus K.S., Agresti C., Lassmann H., Hahne M., Tschopp J., Eugster H.P., Fontana A. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27:1997;3151-3160
39. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822
40. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., Horvat B. Linking innate and acquired immunity. divergent role of CD46 cytoplasmic domains in T cell induced inflammation Nat. Immunol. 3:2002;659-666
41. Matloubian M., Suresh M., Glass A., Galvan M., Chow K., Whitmire J.K., Walsh C.M., Clark W.R., Ahmed R. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:1999;2527-2536
42. Menasche G., Pastural E., Feldmann J., Certain S., Ersoy F., Dupuis S., Wulffraat N., Bianchi D., Fischer A., Le Deist F., de Saint Basile G. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 25:2000;173-176
43. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Kaveri S.V. Cutting edge. human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells J. Immunol. 172:2004;4676-4680
44. Murakami M., Sakamoto A., Bender J., Kappler J., Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA. 99:2002;8832-8837
45. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:2001;629-644
46. Pham C.T., Thomas D.A., Mercer J.D., Ley T.J. Production of fully active recombinant murine granzyme B in yeast. J. Biol. Chem. 273:1998;1629-1633
47. Piccirillo C.A., Letterio J.J., Thornton A.M., McHugh R.S., Mamura M., Mizuhara H., Shevach E.M. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196:2002;237-246
48. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., Miller R.G. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170:2003;3572-3576
49. Ramsdell F. FoxP3 and natural regulatory T cells. Key to a cell lineage? Immunity. 19:2003;165-168
50. Riley-Vargus R.C., Gill D.B., Kemper C., Liszewski M.K., Atkinson J.P. CD46. expanding beyond complement regulation Trends Immunol. 25:2004;496-503
51. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:2002;323-370
52. Sakaguchi S. Regulatory T cells. key controllers of immunologic self-tolerance Cell. 101:2000;455-458
53. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells. their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol. Rev. 182:2001;18-32
54. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118
55. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:2001;37672-37679
56. Shevach E.M. CD4+ CD25+ suppressor T cells. more questions than answers Nat. Rev. Immunol. 2:2002;389-400
57. Somersalo K., Anikeeva N., Sims T.N., Thomas V.K., Strong R.K., Spies T., Lebedeva T., Sykulev Y., Dustin M.L. Cytotoxic T lymphocytes form an antigen-independent ring junction. J. Clin. Invest. 113:2004;49-57
58. Song W.C. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury. Curr. Dir. Autoimmun. 7:2004;181-199
59. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 286:1999;1957-1959
60. Stinchcombe J., Bossi G., Griffiths G.M. Linking albinism and immunity. The secrets of secretory lysosomes Science. 305:2004;55-59
61. Susskind B., Shornick M.D., Iannotti M.R., Duffy B., Mehrotra P.T., Siegel J.P., Mohanakumar T. Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes. Hum. Immunol. 45:1996;64-75